Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms of Belatacept (Nulojix) Effect on Alloimmunity and Antiviral Response After Kidney Transplantation - (BMS Study# IM 103-309)

NCT01953120 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT01953120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01953120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms of Belatacept (Nulojix) Effect on Alloimmunity and Antiviral Response After Kidney Transplantation - (BMS Study# IM 103-309)
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2013
Completion date
April 21, 2021
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplant rejection